vs
DYNAVAX TECHNOLOGIES CORP（DVAX）与MP Materials Corp.（MP）财务数据对比。点击上方公司名可切换其他公司
DYNAVAX TECHNOLOGIES CORP的季度营收约是MP Materials Corp.的1.8倍（$94.9M vs $52.7M），DYNAVAX TECHNOLOGIES CORP净利率更高（28.4% vs 17.9%，领先10.5%），DYNAVAX TECHNOLOGIES CORP同比增速更快（17.7% vs -13.6%），DYNAVAX TECHNOLOGIES CORP自由现金流更多（$32.6M vs $-109.3M），过去两年DYNAVAX TECHNOLOGIES CORP的营收复合增速更高（30.6% vs 4.0%）
Dynavax Technologies Corp是一家处于商业化阶段的生物制药企业，专注于研发和生产针对传染病的创新疫苗及免疫疗法，核心上市产品为成人乙肝疫苗Heplisav-B，主要市场覆盖北美与欧洲，同时拥有多款针对未满足公共卫生需求的在研产品。
MP Materials Corp.是总部位于美国的稀土材料生产商，拥有并运营加利福尼亚州芒廷帕斯矿，这是西半球唯一在产的稀土开采及加工设施，所产核心材料可广泛应用于电动汽车、风力发电机、国防工业等多个关键领域。
DVAX vs MP — 直观对比
营收规模更大
DVAX
是对方的1.8倍
$52.7M
营收增速更快
DVAX
高出31.3%
-13.6%
净利率更高
DVAX
高出10.5%
17.9%
自由现金流更多
DVAX
多$141.9M
$-109.3M
两年增速更快
DVAX
近两年复合增速
4.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $94.9M | $52.7M |
| 净利润 | $26.9M | $9.4M |
| 毛利率 | — | — |
| 营业利润率 | 22.4% | -7.0% |
| 净利率 | 28.4% | 17.9% |
| 营收同比 | 17.7% | -13.6% |
| 净利润同比 | 53.0% | 142.2% |
| 每股收益（稀释后） | $0.21 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DVAXMP
| Q4 25 | — | $52.7M | ||
| Q3 25 | $94.9M | $53.6M | ||
| Q2 25 | $95.4M | $57.4M | ||
| Q1 25 | $68.2M | $60.8M | ||
| Q4 24 | $72.0M | $61.0M | ||
| Q3 24 | $80.6M | $62.9M | ||
| Q2 24 | $73.8M | $31.3M | ||
| Q1 24 | $50.8M | $48.7M |
净利润DVAXMP
| Q4 25 | — | $9.4M | ||
| Q3 25 | $26.9M | $-41.8M | ||
| Q2 25 | $18.7M | $-30.9M | ||
| Q1 25 | $-96.1M | $-22.6M | ||
| Q4 24 | $7.0M | $-22.3M | ||
| Q3 24 | $17.6M | $-25.5M | ||
| Q2 24 | $11.4M | $-34.1M | ||
| Q1 24 | $-8.7M | $16.5M |
营业利润率DVAXMP
| Q4 25 | — | -7.0% | ||
| Q3 25 | 22.4% | -125.2% | ||
| Q2 25 | 15.1% | -76.5% | ||
| Q1 25 | -34.7% | -57.2% | ||
| Q4 24 | -2.3% | -72.1% | ||
| Q3 24 | 12.5% | -62.8% | ||
| Q2 24 | 7.0% | -171.1% | ||
| Q1 24 | -35.0% | -66.6% |
净利率DVAXMP
| Q4 25 | — | 17.9% | ||
| Q3 25 | 28.4% | -78.0% | ||
| Q2 25 | 19.6% | -53.8% | ||
| Q1 25 | -141.0% | -37.2% | ||
| Q4 24 | 9.8% | -36.6% | ||
| Q3 24 | 21.8% | -40.5% | ||
| Q2 24 | 15.4% | -108.9% | ||
| Q1 24 | -17.2% | 33.9% |
每股收益（稀释后）DVAXMP
| Q4 25 | — | $0.07 | ||
| Q3 25 | $0.21 | $-0.24 | ||
| Q2 25 | $0.14 | $-0.19 | ||
| Q1 25 | $-0.77 | $-0.14 | ||
| Q4 24 | $0.07 | $-0.12 | ||
| Q3 24 | $0.12 | $-0.16 | ||
| Q2 24 | $0.08 | $-0.21 | ||
| Q1 24 | $-0.07 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $160.2M | $1.2B |
| 总债务越低越好 | — | $998.7M |
| 股东权益账面价值 | $534.1M | $2.0B |
| 总资产 | $946.5M | $3.9B |
| 负债/权益比越低杠杆越低 | — | 0.50× |
8季度趋势，按日历期对齐
现金及短期投资DVAXMP
| Q4 25 | — | $1.2B | ||
| Q3 25 | $160.2M | $1.1B | ||
| Q2 25 | $99.1M | $261.5M | ||
| Q1 25 | $51.7M | $198.3M | ||
| Q4 24 | $95.9M | $282.4M | ||
| Q3 24 | $119.3M | $284.4M | ||
| Q2 24 | $112.5M | $295.6M | ||
| Q1 24 | $132.0M | $296.5M |
总债务DVAXMP
| Q4 25 | — | $998.7M | ||
| Q3 25 | — | $997.3M | ||
| Q2 25 | — | $910.8M | ||
| Q1 25 | — | $909.8M | ||
| Q4 24 | — | $908.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DVAXMP
| Q4 25 | — | $2.0B | ||
| Q3 25 | $534.1M | $2.0B | ||
| Q2 25 | $494.2M | $1.0B | ||
| Q1 25 | $530.9M | $1.0B | ||
| Q4 24 | $596.8M | $1.1B | ||
| Q3 24 | $681.4M | $1.1B | ||
| Q2 24 | $642.8M | $1.1B | ||
| Q1 24 | $618.5M | $1.1B |
总资产DVAXMP
| Q4 25 | — | $3.9B | ||
| Q3 25 | $946.5M | $3.8B | ||
| Q2 25 | $918.4M | $2.3B | ||
| Q1 25 | $945.9M | $2.4B | ||
| Q4 24 | $986.3M | $2.3B | ||
| Q3 24 | $1.1B | $2.3B | ||
| Q2 24 | $1.0B | $2.4B | ||
| Q1 24 | $986.6M | $2.4B |
负债/权益比DVAXMP
| Q4 25 | — | 0.50× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.88× | ||
| Q4 24 | — | 0.86× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.8M | $-46.9M |
| 自由现金流经营现金流 - 资本支出 | $32.6M | $-109.3M |
| 自由现金流率自由现金流/营收 | 34.4% | -207.4% |
| 资本支出强度资本支出/营收 | 1.3% | 118.5% |
| 现金转化率经营现金流/净利润 | 1.26× | -4.97× |
| 过去12个月自由现金流最近4个季度 | $80.5M | $-328.1M |
8季度趋势，按日历期对齐
经营现金流DVAXMP
| Q4 25 | — | $-46.9M | ||
| Q3 25 | $33.8M | $-42.0M | ||
| Q2 25 | $23.4M | $-3.7M | ||
| Q1 25 | $-19.6M | $-63.2M | ||
| Q4 24 | $53.0M | $30.5M | ||
| Q3 24 | $19.5M | $-6.8M | ||
| Q2 24 | $10.7M | $30.8M | ||
| Q1 24 | $-16.7M | $-41.1M |
自由现金流DVAXMP
| Q4 25 | — | $-109.3M | ||
| Q3 25 | $32.6M | $-92.5M | ||
| Q2 25 | $22.0M | $-32.7M | ||
| Q1 25 | $-23.6M | $-93.7M | ||
| Q4 24 | $49.5M | $-11.2M | ||
| Q3 24 | $18.1M | $-53.3M | ||
| Q2 24 | $9.9M | $-15.6M | ||
| Q1 24 | $-17.4M | $-93.0M |
自由现金流率DVAXMP
| Q4 25 | — | -207.4% | ||
| Q3 25 | 34.4% | -172.8% | ||
| Q2 25 | 23.0% | -56.9% | ||
| Q1 25 | -34.6% | -154.0% | ||
| Q4 24 | 68.8% | -18.3% | ||
| Q3 24 | 22.5% | -84.7% | ||
| Q2 24 | 13.5% | -50.1% | ||
| Q1 24 | -34.3% | -191.0% |
资本支出强度DVAXMP
| Q4 25 | — | 118.5% | ||
| Q3 25 | 1.3% | 94.3% | ||
| Q2 25 | 1.5% | 50.5% | ||
| Q1 25 | 5.8% | 50.1% | ||
| Q4 24 | 4.8% | 68.3% | ||
| Q3 24 | 1.7% | 73.8% | ||
| Q2 24 | 1.1% | 148.7% | ||
| Q1 24 | 1.5% | 106.5% |
现金转化率DVAXMP
| Q4 25 | — | -4.97× | ||
| Q3 25 | 1.26× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.52× | — | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.94× | — | ||
| Q1 24 | — | -2.49× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
MP
| Materials Segment | $35.6M | 68% |
| Other | $17.1M | 32% |
